Oxymorphone Synthesis via Neutral Oxidation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for preparing oxymorphone require lengthy and complex processes with high equipment costs, especially for achieving low levels of alpha-beta-unsaturated ketones, and involve the use of strong acids that compromise purity.
Innovation Solution
A method that oxidizes oripavine to 14-hydroxymorphinone and then reduces it to oxymorphone without using strong acids, eliminating the need for expensive hydrogenation equipment and reducing impurities, thereby producing oxymorphone with low alpha-beta-unsaturated ketone content.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Speed
If strong acid is used in oxidation reaction to accelerate reaction, then reaction speed is improved, but purity of produced oxymorphone deteriorates due to formation of by-products
Solution Approach 1:
The patent changes the chemical parameters of the oxidation system by using neutral or slightly basic conditions (pH 7-11) instead of strong acid conditions. This is achieved by selecting appropriate oxidants (such as peroxides, hypervalent iodine compounds, or metal oxides) that function effectively at neutral to basic pH, thereby eliminating the formation of alpha-beta-unsaturated ketone by-products while maintaining acceptable reaction rates.
2Productivity
If conventional oxidation methods are used, then production speed is improved, but equipment complexity increases due to need for neutralization and purification steps
Solution Approach 1:
The patent extracts and eliminates the problematic neutralization and purification steps from the process by using oxidation methods that do not generate acidic by-products requiring neutralization. The direct oxidation of oripavine to 14-hydroxymorphinone using neutral/basic oxidants avoids the need for subsequent neutralization equipment and simplifies the overall process flow.
Solution Approach 2:
The patent employs oxidants that serve multiple functions: they oxidize oripavine to the desired 14-hydroxymorphinone intermediate while maintaining neutral to basic conditions throughout the reaction. This multi-functionality eliminates the need for separate neutralization steps and reduces equipment requirements for complex purification processes.
3Manufacturing precision
If hydrogenation equipment is used for reduction step, then purity is improved, but cost and equipment complexity increase
Solution Approach 1:
The patent replaces the mechanical hydrogenation system (requiring hydrogen gas supply, catalysts, and pressure control equipment) with chemical reduction methods using metal hydrides or other chemical reducing agents. This substitution eliminates the need for complex hydrogenation equipment while achieving the same reduction of 14-hydroxymorphinone to oxymorphone with high purity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method efficiently produces oxymorphone with reduced levels of alpha-beta-unsaturated ketones, simplifying the purification process and reducing costs, while maintaining high purity levels, particularly with less than 10 ppm of these impurities.
Implementation Method 1
oxidizing oripavine to 14-hydroxymorphinone
Implementation Method 2
reducing the 14-hydroxymorphinone to obtain oxymorphone
Data Source
AI summary
The invention relates to an improved method of preparing oxymorphone or a salt thereof from oripavine. In particular, the invention relates to a method of preparing oxymorphone with a content of alpha-beta-unsaturated ketones (ABUK)<10 ppm, wherein the content of 8,14-dihydroxydihydromorphinone in the prepared oxymorphone is >10 ppm.


